Dennis D. Kim
Chief Executive Officer at Xeno Biosciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Arnold | M | - |
Xeno Biosciences, Inc.
 Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | - |
| Margaret Dalesandro | M | 77 | 4 years | |
| Gordon Hanson | M | 60 |
University of California San Diego
| 23 years |
| Robert W. Conn | M | 81 |
University of California San Diego
| 20 years |
| Michael Koeris | M | - |
Xeno Biosciences, Inc.
Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | - |
| Sanjiv M. Narayan | M | - |
University of California San Diego
| 16 years |
| William Sandborn | M | 61 |
University of California San Diego
| 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patricia Allen | F | 62 | 7 years | |
| Michael Narachi | M | 64 | 9 years | |
| Thomas Hughes | M | 64 | 10 years | |
| Patrick Mahaffy | M | 61 | 9 years | |
| Suzanne McDonald | F | 71 | - | |
| Lloyd Rowland | M | 67 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 12 years |
| Frances K. Heller | F | 57 | 6 years | |
| Avi Y. Goldberg | M | 47 | - | |
| Brian Stuart Murphy | M | 66 | 6 years | |
| Salman Khetani | M | - |
University of California San Diego
| 6 years |
| Ellen Chen | F | - |
University of California San Diego
| 4 years |
| Matthias B. Jaffé | M | 50 | 4 years | |
| Jeffrey Hatfield | M | 66 | - | |
| Franklin J. Miller | M | 83 |
University of California San Diego
| 9 years |
| Eric Lefebvre | M | 60 | 2 years | |
| William O'Connor | M | - |
University of California San Diego
| 5 years |
| Thomas Daniel | M | 69 | 4 years | |
| Bruce Booth | M | 49 | 12 years | |
| Eric Apaydin | M | - |
University of California San Diego
| 5 years |
| Paul G. Marshall | M | 64 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Cameron McDonough | M | 53 | - | |
| Richard Castle | M | - |
University of California San Diego
| 4 years |
| Dawn Viveash | M | 68 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| John LaMattina | M | 74 | 7 years | |
| James Wilson | M | 80 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| James R. Gavin | M | 78 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Teresa Beck | F | 69 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 5 years |
| Michael McFadden | M | 57 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Wendy Dixon | M | 68 | 6 years | |
| Robert Perez | M | 59 | 5 years | |
| Sau Kuen Yu | F | 48 |
University of California San Diego
| 5 years |
| Gary D. Tollefson | M | 72 | 3 years | |
| Lou Tartaglia | M | 60 | 7 years | |
| Yu Shi Shen | M | 46 |
University of California San Diego
| 3 years |
| Marcea Lloyd | F | 75 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Tara Nickerson | M | 51 |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | 3 years |
| Adriana Cabré | F | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 8 years |
| Bill Rote | M | 61 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Karin Eastham | F | 74 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Daniel Cohen | M | 65 |
EnteroMedics, Inc.
 EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 8 years |
| Joseph Hagan | M | 55 | 6 years | |
| Russell W. Felkey | M | 73 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 3 years |
| Brenda Turner | F | - |
University of California San Diego
| 6 years |
| Kevin Starr | M | 61 | 9 years | |
| Peter Honig | M | 67 | 8 years | |
| Frank Thomas | M | 54 | - | |
| Glenn Joseph Busch | M | - |
University of California San Diego
| 8 years |
| Mike Werner | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 years |
| MarySusan Howard | F | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 4 years |
| Joseph Sullivan | M | 81 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 9 years |
| Karthik Balakrishnan | M | - |
University of California San Diego
| 4 years |
| Tom Driscoll | M | - |
University of California San Diego
| 3 years |
| Greg Richardson | M | 42 |
University of California San Diego
| 4 years |
| Danine Kao | M | - |
University of California San Diego
| 5 years |
| Laura Chon | F | - |
University of California San Diego
| 5 years |
| Michelle M. Khoury | F | - |
University of California San Diego
| 4 years |
| Robby Saggu | M | - |
University of California San Diego
| 4 years |
| Mira Chaurushiya | M | - |
University of California San Diego
| 6 years |
| Jared Teo | M | - |
University of California San Diego
| 4 years |
| Dan Mintz | M | - |
University of California San Diego
| 4 years |
| Alice Chen | F | - | 1 years | |
| Calvin Patel | M | - |
University of California San Diego
| 4 years |
| Elena Traistaru | F | 64 | - | |
| Kelly Sexton | F | - |
University of California San Diego
| 5 years |
| Cecilia Ng | F | - |
University of California San Diego
| - |
| Jason Keyes | M | 53 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Sarah L. Hanssen | F | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Loren Baxter | M | - |
University of California San Diego
| 4 years |
| Alain D. Baron | M | 70 |
University of California San Diego
| - |
| Robert Engler | M | 79 |
University of California San Diego
| - |
| Craig A. Eberhard | M | 64 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Roger Marchetti | M | 65 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Joe A. Young | M | 55 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 years |
| Vaughn D. Bryson | M | 85 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 8 years |
| Tom R. Testman | M | 87 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 5 years |
| Dwayne M. Elwood | M | 74 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Steven Altman | M | 62 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 4 years |
| Terrance Gregg | M | 75 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Mark Gergen | M | 61 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Jonathan Mow | M | 59 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 5 years |
| David C. Furlano | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 years |
| Michael R. Hanley | M | 72 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Lisa E. Porter | M | 60 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 9 years |
| David M. Kendall | M | 62 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| Joe J. Lee | M | - |
University of California San Diego
| 4 years |
| Anna E. Crivici | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Julia Brown | F | 76 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| Brandon Mills | M | - |
University of California San Diego
| 5 years |
| Molly A. Holman | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Charles A. Glass | M | - |
University of California San Diego
| 5 years |
| David A. Lee | M | - |
University of California San Diego
| 3 years |
| Kenneth T. Shimizu | M | - |
University of California San Diego
| 13 years |
| Joachim Osther | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dennis D. Kim
- Personal Network
